Yuki Prescott

Yuki is the Director of Clinical Operations. She has 19 years of experience managing and monitoring Phase I – III clinical development programs in adult populations, with the majority of those programs involving products for the treatment of CNS diseases and disorders.

Prior to Arrivo, Yuki was the Assistant Director of Clinical Affairs at Aerial BioPharma, a successful drug development company, where she oversaw the clinical development of multiple products, including the company’s lead product for narcolepsy, acquired by Jazz Pharmaceuticals in 2014. Prior to that, Yuki was a member of the study management team for three large Phase III studies involving a product for the prevention of gastric ulcers while working as an independent consultant at Pozen. Yuki was also an original member of the clinical team at Addrenex Pharmaceuticals, a pharmaceutical development company, sold to Shionogi Pharma in 2009. While at Addrenex, Yuki managed the clinical program of the company’s product for hypertension. Yuki was previously a Project Manager at Lineberry Research Associates, a contract research organization, where she managed and monitored clinical trials for a variety of pharmaceutical companies. Yuki earned a Master’s degree in Physical Therapy from East Carolina University in Greenville, NC, and a BA in Biology from Binghamton University in Binghamton, NY.